Sensus Healthcare Inc. logo

Sensus Healthcare Inc. (SRTS)

Market Closed
2 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
3. 25
-0.08
-2.4024%
$
58.28M Market Cap
- P/E Ratio
- Div Yield
1,165 Volume
-0.2 Eps
$ 3.33
Previous Close
Add Transaction
Day Range
3.22 3.38
Year Range
2.66 5.49
Want to track SRTS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today

Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today

Sensus Healthcare, Inc. (SRTS) reached $4.44 at the closing of the latest trading day, reflecting a +2.54% change compared to its last close.

Zacks | 1 year ago
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors

Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors

Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.

Zacks | 1 year ago
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates

Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates

Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.14 per share a year ago.

Zacks | 1 year ago
Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know

Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.22, marking a -0.47% move from the previous day.

Zacks | 1 year ago
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline

Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q1 Earnings Expected to Decline

Sensus Healthcare (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?

Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 1 year ago
Sensus Healthcare, Inc. (SRTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Sensus Healthcare, Inc. (SRTS) Rises Yet Lags Behind Market: Some Facts Worth Knowing

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.69, marking a +1.3% move from the previous day.

Zacks | 1 year ago
Sensus Healthcare, Inc. (SRTS) Increases Despite Market Slip: Here's What You Need to Know

Sensus Healthcare, Inc. (SRTS) Increases Despite Market Slip: Here's What You Need to Know

Sensus Healthcare, Inc. (SRTS) reachead $4.48 at the closing of the latest trading day, reflecting a +0.45% change compared to its last close.

Zacks | 1 year ago
Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts

Sensus Healthcare, Inc. (SRTS) Rises As Market Takes a Dip: Key Facts

Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.69, moving +1.08% from the previous trading session.

Zacks | 1 year ago
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today

Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today

Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.78, moving +0.84% from the previous trading session.

Zacks | 1 year ago
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet

Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks | 1 year ago
Sensus Healthcare: A Tough Q1 2025 Awaits Ahead

Sensus Healthcare: A Tough Q1 2025 Awaits Ahead

Q4 2024 showed a significant miss in profitability despite a 4% YoY sales growth; gross profit margin dropped due to a one-time discount for a new big client. The FDA initiatives are interesting, but they will bring a slowdown in sales as they are fully rolled out. Management has warned of a Q1 2025 with considerably lower sales due to the Fair Deal Agreements and seasonal factors.

Seekingalpha | 1 year ago
Loading...
Load More